ALVO
AlvotechNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.10B
P/E Ratio
35.20
EPS
$0.10
Beta
0.25
52W High
$11.85
52W Low
$3.03
50-Day MA
$3.70
200-Day MA
$6.07
Dividend Yield
—
Profit Margin
4.74%
Forward P/E
7.91
PEG Ratio
—
About Alvotech
Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.
Fundamentals
| Revenue (TTM) | $588.90M |
| Gross Profit (TTM) | $353.35M |
| EBITDA | $103.98M |
| Operating Margin | 33.80% |
| Return on Equity | 0.00% |
| Return on Assets | 3.82% |
| Revenue/Share (TTM) | $2.03 |
| Book Value | $-0.91 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 1.86 |
| EV/Revenue | 3.934 |
| EV/EBITDA | 7.41 |
| Quarterly Earnings Growth (YoY) | -58.40% |
| Quarterly Revenue Growth (YoY) | 10.10% |
| Shares Outstanding | $312.05M |
| Float | $114.09M |
| % Insiders | 62.75% |
| % Institutions | 6.07% |
Historical Volatility
HV 10-Day
53.30%
HV 20-Day
68.52%
HV 30-Day
68.09%
HV 60-Day
60.57%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($13.83 target)
1
Strong Buy3
Buy1
Hold1
Strong SellData last updated: 4/29/2026